S0120 G.E.M.S. Genomics encounters mgus and smm

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In this issue of Blood, Dhodapkar et al1 present the first US cooperative group trial in asymptomatic monoclonal gammopathies that prospectively examines state-of-the-art laboratory, genomic, and imaging as potential predictors for progression to active multiple myeloma.

Original languageEnglish (US)
Pages (from-to)4-5
Number of pages2
JournalBlood
Volume123
Issue number1
DOIs
StatePublished - Jan 2 2014

Fingerprint

Paraproteinemias
Genomics
Multiple Myeloma
Blood
Imaging techniques

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

S0120 G.E.M.S. Genomics encounters mgus and smm. / Dispenzieri, Angela.

In: Blood, Vol. 123, No. 1, 02.01.2014, p. 4-5.

Research output: Contribution to journalArticle

@article{7a0155f87cdf41e4b0024f248b38235d,
title = "S0120 G.E.M.S.: Genomics encounters mgus and smm",
abstract = "In this issue of Blood, Dhodapkar et al1 present the first US cooperative group trial in asymptomatic monoclonal gammopathies that prospectively examines state-of-the-art laboratory, genomic, and imaging as potential predictors for progression to active multiple myeloma.",
author = "Angela Dispenzieri",
year = "2014",
month = "1",
day = "2",
doi = "10.1182/blood-2013-11-535575",
language = "English (US)",
volume = "123",
pages = "4--5",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - S0120 G.E.M.S.

T2 - Genomics encounters mgus and smm

AU - Dispenzieri, Angela

PY - 2014/1/2

Y1 - 2014/1/2

N2 - In this issue of Blood, Dhodapkar et al1 present the first US cooperative group trial in asymptomatic monoclonal gammopathies that prospectively examines state-of-the-art laboratory, genomic, and imaging as potential predictors for progression to active multiple myeloma.

AB - In this issue of Blood, Dhodapkar et al1 present the first US cooperative group trial in asymptomatic monoclonal gammopathies that prospectively examines state-of-the-art laboratory, genomic, and imaging as potential predictors for progression to active multiple myeloma.

UR - http://www.scopus.com/inward/record.url?scp=84891784806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891784806&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-11-535575

DO - 10.1182/blood-2013-11-535575

M3 - Article

AN - SCOPUS:84891784806

VL - 123

SP - 4

EP - 5

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -